22nd century group receives additional $3.7 million from cash exercise of outstanding warrants

Williamsville, n.y., march 12, 2021 (globe newswire) -- 22nd century group, inc. (nyse american: xxii), a leading plant-based, biotechnology company focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, today announced that it has received an additional $3.7 million, for total net proceeds of $11.8 million, from the completion of the cash exercise of warrants during february and march of 2021. following this transaction, the company is free of any outstanding warrants.
XXII Ratings Summary
XXII Quant Ranking